eISSN: 2299-551X
ISSN: 0011-4553
Journal of Stomatology
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2023
vol. 76
 
Share:
Share:
Original paper

Investigation of cyto-toxicity of an innovative BIOfactor MTA product in different human cells: a pilot study

Gülter Devrim Akyol
1
,
Mukadder Inci Baser Kolcu
2
,
Nazlı Zeynep Alpaslan
3
,
Filiz Taşpınar
4
,
Rodi Yusuf Mızrak
5
,
Serap Keskin Tunç
5
,
Bülend İnanç
6

  1. Endodontics, Dentiora Dental Clinic, Turkey
  2. Department of Medical Education and Informatics, Süleyman Demirel University, Faculty of Medicine, Turkey
  3. Department of Periodontology, Van Yüzüncü Yıl University, Faculty of Dentistry, Turkey
  4. Department of Physiology, Aksaray University, Faculty of Medicine, Turkey
  5. Department of Oral and Maxillofacial Surgery, Hamidiye Faculty of Dentistry, University of Health Sciences, Turkey
  6. Department of Periodontology, Trakya University, Faculty of Dentistry, Turkey
J Stoma 2023; 76, 2: 71-76
Online publish date: 2023/06/26
Article file
- Investigation.pdf  [0.26 MB]
Get citation
 
PlumX metrics:
 

Introduction

Repair techniques are quite important in conservative dentistry approach in order to keep the tooth healthy in the mouth [1, 2]. Mineral trioxide aggregate (MTA) is a bio-compatible material that is frequently used for this purpose [3, 4]. MTA is utilized for conservative root fracture repair [2], perforation repair [5], pulp capping [6], apical plug formation for apexification [7], retrograde fillings in apical surgery [8], and coronal barrier formation [1] in re-vascularization treatment. MTA interacts with live tissues and body fluids in all these applications, and these chemical/biological interactions produce changes in physical properties of this biological milieu [9, 10].
Since the early 1990s, MTA’s physical, chemical, and biological properties have been studied [11, 12]. Certainly, new components were introduced into the MTA structure to find the optimal combination. An ideal endodontic material should have properties, such as covering [13], dimensional stability [14, 15], color stability [16, 17], radiopacity, non-dissolution in interaction with body fluids [18], and fluency and easy placement [19] as well as alkaline pH, calcium ion release [20], bio-activity [21], and cell attachment and bio-compatibility [22].
While many of these features are available in MTA, some are missing. Color stability and consistency are continuous concerns for MTA, and materials need to be improved in these areas [15]. Therefore, different materials are introduced to the market.
A brand-new root repair material called BIOfactor MTA was released on the market. It is advised to use the same powder and liquid mixture as with other brands; however, it is asserted that BIOfactor MTA’s powder is now better and finer. Setup duration, hydration time, and color stability have all been improved as a result of this change. Additionally, the company asserted that depending on clinician’s desired preference, the cement may be made in either a flowable or thick consistency [23].

Objectives

The present study aimed to compare the cyto-toxi­city of Biodentine (Septodont, Saint-Maur-des-Fosses, France) and White Angelus MTA (Angelus, Brazil) brand products, which are available on the market, with BİOfactor MTA (Imicryl Dental, Konya, Turkey) that has been currently released in Turkey on 3T3L-1 fibroblast and Saos-2 osteosarcoma cell lines, and to find the most appropriate dilution that can be used in future studies.

Material and methods

In the study, three different calcium silicate-based products were examined to evaluate their cytotoxicity, including Biodentine (Septodont, France) (BD), White Angelus MTA (Angelus, Brazil) (WAM), and BİOfactor MTA (Imıcryl Dental, Turkey) (BM).
Preparation of specimens
Extraction liquids were collected in three wells of a 24-well plate. BD, WAM, and BM materials were prepared according to manufacturers’ instructions. The thickness of each sample was 2 mm, and they were sterilized by exposing to ultraviolet (UV) light for 30 minutes.
Obtaining extraction liquid
The prepared and sterilized samples were filled with DMEM (Dulbecco’s modified eagle medium, Biochrom Ag; Germany) and cultured for 24 hours in a 37°C incubator containing 5% CO2. After 24 hours, DMEM solutions were collected again. These solutions were considered as super-solutions.
Investigation of cyto-toxic properties of BD, WAM, and BM
MTT test was performed to determine materials’ cyto-toxicity potential, and it was carried out in the cell culture laboratory. 3T3L-1 fibroblast and Saos-2 osteo­sarcoma cell lines were used in cyto-toxicity assay. The cells were cultured at 37°C in a humidified 5% CO2 atmosphere, and were maintained in the completed medium of Dulbecco’s modified eagle medium (DMEM) with high glucose (Capricorn, CP18-2472) supplemented with 10% fetal bovine serum (FBS) (Biological İndustries-04-001), 1% L-glutamine (Capricorn, GLN-B), and Penicilin (100 U/ml)-streptomycin (100 μg/ml) (Capricorn, CP15-1396). Active cells in logarithmic growth phase, which covered 80-85 percent of the surface of the flask were plated in each well in a 96-well plate. For each well, 10,000 cells were plated and incubated for adaptation for 24 hours. The prepared super-solution was diluted at 1 : 1, 1 : 2, 1 : 4, and 1 : 8 ratios, and were used for MTT test. After incubation, DMEM medium was removed. New extraction liquid medium that was previously prepared at 1 : 1, 1 : 2, 1 : 4, and 1 : 8 dilutions were added to each well and incubated for 24 hours. DMEM medium containing 10% FBS was used as the control group. Following incubation, MTT test was performed. MTT dye was homogenized by combining it with DMEM medium that did not contain phenol red, and a stock MTT solution was prepared at a final concentration of 5 mg/ml. The medium of each well was discarded, and MTT solution in 10% of completed medium was added to each well and incubated for 3 hours at 37°C. Afterwards, lysis solution (1% triton-X, 10% 0.1 mol/1 HCl, 89% isopropanol) was added to each well. Optical density of the produced formazan was calculated using spectrophotometer readings at 570 and 630 nanometers as a reference. All experimental procedures and MTT test were repeated four times.
Statistical analysis
SPSS package program was applied for statistical analy­sis of the data. Kruskal-Wallis method was used to compare groups and dilutions for analyzing cell viability data, because the number of observations within the groups was limited and it did not provide the assumption of normal distribution. Lettering was done in cases where there was a statistically significant difference by using corrected p-values from paired comparisons.

Results

There was a statistically significant difference in cell viability in the BD group in the 3T3L-1 fibroblast cell line (p < 0.05). The statistical significance of 1 : 4 and 1 : 8 dilutions was the same as that of the negative control group; however, 1 : 2 and 1 : 1 dilutions had a statistically significant negative effect on cell viability. The positive control group had a statistically significant negative impact on cell viability when compared with the other groups (Table 1).
In the 3T3l-1 fibroblast cell line, a statistically significant change in cell viability was identified in the WAM group (p < 0.05). The statistical significance of 1 : 4 and 1 : 8 dilutions was the same as that of the negative control group; however, 1 : 2 and 1 : 1 dilutions had a statistically significant negative effect on cell viability. The positive control group presented a statistically significant negative impact on cell viability when compared with the other groups (Figure 1).
Statistically significant difference was found in 3T3l-1 fibroblast cell line in terms of cell viability in the BM group (p < 0.05). The statistical significance of 1 : 4 and 1 : 8 dilutions was the same as that of the negative control group; however, 1 : 2 and 1 : 1 dilutions showed a statistically significant negative effect on cell viability. The positive control group had a statistically significant negative impact on cell viability when compared with the other groups.
In the BD group, there was a statistically significant difference in cell viability in Saos-2 osteosarcoma cell line (p < 0.05). The statistical significance of 1 : 4 and 1 : 8 dilutions was the same as that of the negative control group; however, 1 : 2 and 1 : 1 dilutions showed a statistically significant negative effect on cell viability. The positive control group had a statistically significant negative impact on cell viability when compared with the other groups.
In the Saos-2 osteosarcoma cell line, a statistically significant difference in cell viability was reported in the WAM group (p < 0.05). The statistical significance of 1 : 4 and 1 : 8 dilutions was the same as that of the negative control group; however, 1 : 2 and 1 : 1 dilutions demonstrated a statistically significant negative effect on cell viability. The positive control group had a statistically significant negative impact on cell viability when compared with the other groups (Table 1).
In the BM group, there was a statistically significant difference in cell viability in the Saos-2 osteosarcoma cell line (p < 0.05). The statistical significance of 1 : 4 and 1 : 8 dilutions was the same as that of the negative control group; however, 1 : 2 and 1 : 1 dilutions showed a statistically significant negative effect on cell viability. The positive control group had a statistically significant negative impact on cell viability when compared with the other groups (Figure 2). When each dilution was examined separately, no statistical difference between the groups was discovered (p > 0.05).

Discussion

In dentistry, vital pulp therapy has been applied more reliably, and the success of perforation repairs has increased in endodontics with the introduction of bio-ceramic materials to the market. Certainly, these materials have expanded by gaining many different properties. This variety is possible with items’ various constituents. This differentiates the cyto-toxicity of these products on live fibroblast cells. These compounds have been shown to induce dentin development in the wounded pulp as well as enhance dental pulp vitality in vital pulp therapies [24]. Capping materials must be safe and support pulp health in living pulp [25]. MTA is a bio-active cement introduced to the market by Torabinejad in the early 1990s as a viable physical endodontic repair and root-end filling material [26]. It has been proven that MTA induces mineralization of the exposed pulp, and has the potential to preserve pulp vitality. As a result, MTA’s indications for the use have grown dramatically since its’ initial application, and recently has been recognized as a superior material over Ca(OH)2 in many clinical applications [27, 28]. To offer radiopacity, MTA powder is a refined combination of Portland cement and bismuth oxide. This cement’s main component phases include tricalcium and dicalcium silicates as well as tricalcium aluminate [29, 30]. That is why white MTA to the materials tested in our study was added.
In the response to limitations of MTA, BD introduced a novel tricalcium silicate-based cement to the market. This relatively new bio-material is claimed to have similar qualities as MTA, and is now being researched for crucial pulp therapy techniques. BD is designed as a permanent, bio-compatible dentin substitute that can be applied to the full volume of the cavity in a single-session, or in an observation period before composite restoration using the sandwich approach [31]. Second tested material in the current study was BD.
BM is a new type of calcium silicate-based cement that was recently released for pulp capping, pulpotomies, apexification, root perforation repairs, root-end filling, and apical plug treatments. The components of BM powder include tricalcium and dicalcium silicate, tricalcium aluminate, and ytterbium oxide. The liquid is composed of water-soluble carboxylated polymer and demineralized water in amounts ranging from 0.5 to 3%. Depending on the type of treatment, this cement can be made in a fluid or dense form. BM, according to the manufacturer, has a finer powder for faster hydration, easier handling features, stronger sealing, and a shorter curing time, and it does not cause tooth discoloration. Additionally, BM seems to be a more cost-efficient product [32].
In our investigation, we intended to compare the cyto-toxicity of this new product to that of BD that the authors described as gold standard for the application in endodontics. According to our readings, there is no literature on cyto-toxicity related to BM.
The effects of various bio-materials on cell viability and osteogenic gene expression are crucial for tissue engineering and regenerative medicine. Many studies have been conducted to investigate the survival of cells and the expression of various osteogenic markers in pulp capping materials [33]. Because it grows quickly and is resistant, the fibroblast cell line was chosen for this investigation for its’ ease of usage. Due to their reproducibility, established cell lines, such as these, have been suggested by
ISO for testing biological responses of dental materials [34].
In general, cell viability assays assess the effects of the tested substance on cell growth and cyto-toxicity. Tetrazolium reduction, resazurin reduction, and protease activity tests are the most often used types of assays, which determine the metabolism or enzymatic activity of living cells. Another test that can be applied in this regard is luminogenic ATP experiment. The rate of viable cells is assessed directly in this experiment by measuring the amount of ATP. Although the ATP test is the fastest and most sensitive, inexpensive tests with adequate performance are more commonly used. Among them, the most used are MTS, XTT, WST-1, and MTT [35].
We chose the MTT assay to investigate the cyto-toxic effect of BD, WAM, and BM bio-materials on fibroblasts and osteosarcomas in our investigation. We accomplished this by testing the impact of all dilutions on cyto-toxicity using the extract, which was generated directly and in varying dilutions. While 1 : 1 and 1 : 2 diluted solutions were cyto-toxic to fibroblasts and osteosarcoma cells, 1 : 4 and 1 : 8 diluted solutions were not.
Youssef et al. [24] obtained similar results to those of the present study. Proroot MTA, BD, Ca (OH)2, and Emdogain were employed in this research, and it was discovered that all these compounds presented various cyto-toxic effects on dental pulp cells.
Rather than our findings, in a study by Zhou et al. [36], 1 : 1 and 1 : 2 dilutions of BD and AM did not show cyto-toxic effects on fibroblasts.

Conclusions

In terms of cyto-toxicity, the findings of the current study indicate that the recently released BM should not be treated differently than WAM and BD. Since it is a less expensive and domestically produced substance, it appears to be safe in use regarding cyto-toxicity. According to the findings, it seems appropriate to use 1 : 4 and 1 : 8 diluted solutions in the biological compatibility assessment tests to be performed with these substances.
Acknowledgement
This study was supported by Van Yüzüncü Yıl University Scientific Project Presidency, with project number TSA-2018-6444.

Conflict of interest

The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
1. Camilleri J. Evaluation of the physical properties of an endodontic Portland cement incorporating alternative radiopacifiers used as root-end filling material. Int Endod J 2010; 43: 231-240.
2. Camilleri J, Gandolfi MG, Siboni F, Prati C. Dynamic sealing ability of MTA root canal sealer. Int Endod J 2011; 44: 9-20.
3. Marciano MA, Costa RM, Camilleri J, Mondelli RFL, Guimarães BM, Duarte MAH. Assessment of color stability of white mineral trioxide aggregate angelus and bismuth oxide in contact with tooth structure. J Endod 2014; 40: 1235-1240.
4. Marciano MA, Camilleri J, Costa RM, Matsumoto MA, Guima­rães BM, Duarte MAH. Zinc oxide inhibits dental discoloration caused by white mineral trioxide aggregate angelus. J Endod 2017; 43: 1001-1007.
5. Islam I, Chng HK, Yap AUJ. Comparison of the physical and mechanical properties of MTA and portland cement. J Endod 2006; 32: 193-197.
6. Vivan RR, Ordinola-Zapata R, Bramante CM, Bernardineli N, Garcia RB, Duarte MAH, et al. Evaluation of the radiopacity of some commercial and experimental root-end filling materials. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 35-38.
7. Cavenago BC, Pereira TC, Duarte MH, Ordinalo-Zapata R, Marciano CM, Bramente CM, et al. Influence of powder-to-water ratio on radiopacity, setting time, pH, calcium ion release and a micro-­CT volumetric solubility of white mineral trioxide aggregate. Int Endod J 2014; 47: 120-126.
8. Hungaro Duarte MA, Minotti PG, Rodrigues CT, Ordinalo Zapata R, Bramante CM, Filho MT, et al. Effect of different radiopacifying agents on the physicochemical properties of white Portland cement and white mineral trioxide aggregate. J Endod 2012; 38: 394-397.
9. Hungaro Duarte MAH, de Oliveira Demarchi ACC, Yamashita JC, Kuga MC, de Campos Fraga S. pH and calcium ion release of 2 root-end filling materials. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 345-347.
10. Gandolfi MG, Taddei P, Tinti A, Prati C. Apatite-forming ability (bioactivity) of ProRoot MTA. Int Endod J 2010; 43: 917-929.
11. Camilleri J, Montesin FE, Di Silvio L, Pitt Ford TR. The chemical constitution and biocompatibility of accelerated Portland cement for endodontic use. Int Endod J 2005; 38: 834-842.
12. https://www.imicryl.com/biofactor-mta_56_u_tr.html
13. Youssef AR, Emara R, Taher MM, Al-Allaf FA, Almaki M, Almasri MA, et al. Effects of mineral trioxide aggregate, calcium hydro­xide, biodentine and Emdogain on osteogenesis, Odontogenesis, angiogenesis and cell viability of dental pulp stem cells. BMC Oral Health 2019; 19: 133. DOI: doi: 10.1186/s12903-019-0827-0.
14. Kisby L. Vital pulp therapy in primary teeth: an update. Dent Today 2016; 35: 112-113.
15. Torabinejad M, Watson TF, Pitt Ford TR. Sealing ability of a mineral trioxide aggregate when used as a root end filling material. J Endod 1993; 19: 591-595.
16. Tüzüner T, Alacam A, Altunbas DA, Gokdogan FG, Gundogdu E. Clinical and radiographic outcomes of direct pulp capping therapy in primary molar teeth following haemostasis with various antiseptics: a randomised controlled trial. Eur J Paediatr Dent 2012; 13: 289-292.
17. Zhu C, Ju B, Ni R. Clinical outcome of direct pulp capping with MTA or calcium hydroxide: a systematic review and meta-analysis. Int J Clin Exp Med 2015; 8: 17055-17060.
18. Camilleri J. The chemical composition of mineral trioxide aggregate. J Conserv Dent 2008; 11: 141-143.
19. Kaup M, Schäfer E, Dammaschke T. An in vitro study of different material properties of Biodentine compared to ProRoot MTA. Head Face Med 2015; 11: 16. DOI: doi: 10.1186/s13005-015-0074-9.
20. da Fonseca TS, da Silva GF, Tanomaru-Filho M, Sasso-Cerri E, Guerreiro-Tanomaru JM, Cerri PS. In vivo evaluation of the inflammatory response and IL-6 immunoexpression promoted by Biodentine and MTA Angelus. Int Endod J 2016; 49: 145-153.
21. Akbulut MB, Bozkurt DA, Terlemez A, Akman M. The push-out bond strength of BIOfactor mineral trioxide aggregate, a novel root repair material. Restor Dent Endod 2019; 44: e5. doi: 10.5395/rde.2019.44.e5.
22. Ajlan SA, Ashri NY, Aldahmash AM, Alnbaheen MS. Osteogenic differentiation of dental pulp stem cells under the influence of three different materials. BMC Oral Health 2015; 15: 132. DOI: doi: 10.1186/s12903-015-0113-8.
23. Association for the Advancement of Medical Instrumentation/International Organization for Standardization). Biological evaluation of medical devices part 5: test for in vitro cytotoxicity (ISO 10993–10995:2009). Arlington, VA: Association for the Advancement of Medical Instrumentation; 2009.
24. Riss TL, Moravec RA, Niles AL. Cell Viability Assays. In: Markossian S, Grossman A, Brimacombe K, et al. (eds.). Assay Guidance Manual. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004 (Accessed: 03.12.2021).
25. Zhou HM, Shen Y, Wang ZJ, Zheng YF, Hakkinen L, Haapasalo M. In vitro cytotoxicity evaluation of a novel root repair material. J Endod 2013; 39: 478-483.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.